Three novel biomarkers (SCG2, ASPN, and GEM) were screened, and the findings are displayed in Figure 5A. The genes (EGR1, SLIT2, and FOS) were rejected because they were previously correlated with the development of endometriosis in the literature. The gene discussed is SCG2; the disease is endometriosis.